Concordance of macular pigment measurement using customized heterochromatic flicker photometry and fundus autofluorescence in age-related macular degeneration

Investigative Ophthalmology and Visual Science

Volumn 56, Issue 13, 2015, Pages 8207-8214

  Akuffo, Kwadwo Owusu ^a   Beatty, Stephen ^a   Stack, Jim ^a   Peto, Tunde ^b   Leung, Irene ^b   Corcoran, Laura ^a   Power, Rebecca ^a   Nolan, John M ^a  

^a South East Technological University   (Ireland)

^b MOORFIELDS EYE HOSPITAL   (United Kingdom)

Author keywords

Age related macular degeneration; Agreement; Concordance; Customized heterochromatic flicker photometry; Fundus autofluorescence; Macular pigment

Indexed keywords

VISUAL PIGMENT;

ADULT; AGE RELATED MACULAR DEGENERATION; AGED; ARTICLE; AUTOFLUORESCENCE; CATARACT; CLINICAL TRIAL; CORRELATION COEFFICIENT; CRITICAL FLICKER FUSION; DENSITOMETER; DENSITOMETRY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OPTICAL COHERENCE TOMOGRAPHY DEVICE; PHOTOMETRY; PRIORITY JOURNAL; VERY ELDERLY; VISUAL ACUITY; VISUAL SYSTEM EXAMINATION; CONTROLLED STUDY; EYE FUNDUS; FLUORESCENCE ANGIOGRAPHY; MACULAR DEGENERATION; METABOLISM; PROCEDURES; RANDOMIZED CONTROLLED TRIAL; REPRODUCIBILITY;

ADULT; AGED; AGED, 80 AND OVER; DENSITOMETRY; FEMALE; FLUORESCEIN ANGIOGRAPHY; FUNDUS OCULI; HUMANS; MACULAR DEGENERATION; MACULAR PIGMENT; MALE; MIDDLE AGED; PHOTOMETRY; REPRODUCIBILITY OF RESULTS;

EID: 84952933443     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.15-17822     Document Type: Article

References (41)

1. Landrum JT, Bone RA. Lutein, zeaxanthin, and the macular pigment. Arch Biochem Biophys. 2001;385:28-40.
2. Snodderly DM, Brown PK, Delori FC, Auran JD. The macular pigment. 1. Absorbance spectra, localization, and discrimination from other yellow pigments in primate retinas. Invest Ophthalmol Vis Sci. 1984;25:660-673.
3. Trieschmann M, van Kuijk FJ, Alexander R, et al. Macular pigment in the human retina: histological evaluation of localization and distribution. Eye (Lond). 2008;22:132-137.
4. Khachik F, Bernstein PS, Garland DL. Identification of lutein and zeaxanthin oxidation products in human and monkey retinas. Invest Ophthalmol Vis Sci. 1997;38:1802-1811.
5. Bernstein PS, Khachik F, Carvalho LS, Muir GJ, Zhao DY, Katz NB. Identification and quantitation of carotenoids and their metabolites in the tissues of the human eye. Exp Eye Res. 2001;72:215-223.
6. Tian Y, Kijlstra A, van der Veen RL, Makridaki M, Murray IJ, Berendschot TT. Lutein supplementation leads to decreased soluble complement membrane attack complex sC5b-9 plasma levels. Acta Ophthalmol. 2015;93:141-145.
7. Tian Y, Kijlstra A, van der Veen RL, Makridaki M, Murray IJ, Berendschot TT. The effect of lutein supplementation on blood plasma levels of complement factor D, C5a and C3d. PLoS One. 2013;8:e73387.
8. Li SY, Fung FK, Fu ZJ, Wong D, Chan HH, Lo AC. Anti-inflammatory effects of lutein in retinal ischemic/hypoxic injury: in vivo and in vitro studies. Invest Ophthalmol Vis Sci. 2012;53:5976-5984.
9. Firdous AP, Kuttan G, Kuttan R. Anti-inflammatory potential of carotenoid meso-zeaxanthin and its mode of action. Pharm Biol. 2015;53:961-967.
10. Loughman J, Davison PA, Nolan JM, Akkali MC, Beatty S. Macular pigment and its contribution to visual performance and experience. J Optom. 2010;3:74-90.
11. Sabour-Pickett S, Nolan JM, Loughman J, Beatty S. A review of the evidence germane to the putative protective role of the macular carotenoids for age-related macular degeneration. Mol Nutr Food Res. 2011;56:270-286.
12. Igras E, Loughman J, Ratzlaff M, O’Caoimh R, O’Brien C. Evidence of lower macular pigment optical density in chronic open angle glaucoma. Br J Ophthalmol. 2013;97:994-998.
13. Nolan JM, Loskutova E, Howard AN, et al. Macular pigment, visual function, and macular disease among subjects with alzheimer’s disease: an exploratory study. J Alzheimer’s Dis. 2014;42:1191-1202.
14. Scanlon G, Connell P, Ratzlaff M, et al. Macular pigment optical density is lower in type 2 diabetes, compared with type 1 diabetes and normal controls. Retina. 2015;35:1808-1816.
15. Lima VC, Rosen RB, Maia M, et al. Macular pigment optical density measured by dual-wavelength autofluorescence imaging in diabetic and nondiabetic patients: a comparative study. Invest Ophthalmol Vis Sci. 2010;51:5840-5845.
16. Liu R, Wang T, Zhang B, et al. Lutein and zeaxanthin supplementation and association with visual function in age-related macular degeneration. Invest Ophthalmol Vis Sci. 2015;56:252-258.
17. Akuffo KO, Nolan JM, Howard AN, et al. Sustained supplementation and monitored response with differing carotenoid formulations in early age-related macular degeneration. Eye (Lond). 2015;29:902-912.
18. Ma L, Yan SF, Huang YM, et al. Effect of lutein and zeaxanthin on macular pigment and visual function in patients with early age-related macular degeneration. Ophthalmology. 2012;119: 2290-2297.
19. Loughman J, Nolan JM, Howard AN, Connolly E, Meagher K, Beatty S. The impact of macular pigment augmentation on visual performance using different carotenoid formulations. Invest Ophthalmol Vis Sci. 2012;53:7871-7880.
20. Hammond BR, Fletcher LM, Roos F, Wittwer J, Schalch W. A double-blind, placebo-controlled study on the effects of lutein and zeaxanthin on photostress recovery, glare disability, and chromatic contrast. Invest Ophthalmol Vis Sci. 2014;55:8583-8589.
21. Johnson EJ. A possible role for lutein and zeaxanthin in cognitive function in the elderly. Am J Clin Nutr. 2012;96: 1161S-1165S.
22. Johnson EJ. Role of lutein and zeaxanthin in visual and cognitive function throughout the lifespan. Nutr Rev. 2014;72: 605-612.
23. Dennison JL, Stack J, Beatty S, Nolan JM. Concordance of macular pigment measurements obtained using customized heterochromatic flicker photometry, dual-wavelength auto- fluorescence, and single-wavelength reflectance. Exp Eye Res. 2013;116:190-198.
24. Akuffo KO, Beatty S, Stack J, et al. Central Retinal Enrichment Supplementation Trials (CREST): design and methodology of the CREST randomized controlled trials. Ophthalmic Epidemiol. 2014;21:111-123.
25. Davis MD, Gangnon RE, Lee LY, et al. The Age-Related Eye Disease Study severity scale for age-related macular degeneration: AREDS Report No. 17. Arch Ophthalmol. 2005;123: 1484-1498.
26. Wooten BR, Hammond BR, Land RI, Snodderly DM. A practical method for measuring macular pigment optical density. Invest Ophthalmol Vis Sci. 1999;40:2481-2489.
27. Stringham JM, Hammond BR, Nolan JM, et al. The utility of using customized heterochromatic flicker photometry (cHFP) to measure macular pigment in patients with age-related macular degeneration. Exp Eye Res. 2008;87:445-453.
28. Delori FC, Goger DG, Hammond BR, Snodderly DM, Burns SA. Macular pigment density measured by autofluorescence spectrometry: comparison with reflectometry and heterochromatic flicker photometry. J Opt Soc Am A Opt Image Sci Vis. 2001;18:1212-1230.
29. Wustemeyer H, Jahn C, Nestler A, Barth T, Wolf S. A new instrument for the quantification of macular pigment density: first results in patients with AMD and healthy subjects. Graefes Arch Clin Exp Ophthalmol. 2002;240:666-671.
30. Trieschmann M, Heimes B, Hense H, Pauleikhoff D. Macular pigment optical density measurement in autofluorescence imaging: comparison of one- and two-wavelength methods. Graefes Arch Clin Exp Ophthalmol. 2006;244:1565-1574.
31. Delori FC. Autofluorescence method to measure macular pigment optical densities fluorometry and autofluorescence imaging. Arch Biochem Biophys. 2004;430:156-162.
32. Delori FC. Spectrophotometer for noninvasive measurement of intrinsic fluorescence and reflectance of the ocular fundus. Appl Opt. 1994;33:7439-7452.
33. Delori FC, Dorey CK, Staurenghi G, Arend O, Goger DG, Weiter JJ. In vivo fluorescence of the ocular fundus exhibits retinal pigment epithelium lipofuscin characteristics. Invest Ophthalmol Vis Sci. 1995;36:718-729.
34. Chylack LT Jr, Wolfe JK, Singer DM, et al. The Lens Opacities Classification System III. The Longitudinal Study of Cataract Study Group. Arch Ophthalmol. 1993;111:831-836.
35. R Core team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2008.
36. Lin L, Hedayat AS, Wu W. Statistical Tools for Measuring Agreement. New York, NY: Springer; 2012.
37. Ciulla TA, Hammond BR Jr, Yung CW, Pratt LM. Macular pigment optical density before and after cataract extraction. Invest Ophthalmol Vis Sci. 2001;42:1338-1341.
38. Nolan JM, O’Reilly P, Loughman J, et al. Augmentation of macular pigment following implantation of blue light-filtering intraocular lenses at the time of cataract surgery. Invest Ophthalmol Vis Sci. 2009;50:4777-4785.
39. Sasamoto Y, Gomi F, Sawa M, Sakaguchi H, Tsujikawa M, Nishida K. Effect of cataract in evaluation of macular pigmentoptical density by autofluorescence spectrometry. Invest Ophthalmol Vis Sci. 2011;52:927-932.
40. Sharifzadeh M, Obana A, Gohto Y, Seto T, Gellermann W. Autofluorescence imaging of macular pigment: influence and correction of ocular media opacities. J Biomed Opt. 2014;19: 96010.
41. Trieschmann M, Heimes B, Hense HW, Pauleikhoff D. Macular pigment optical density measurement in autofluorescence imaging: comparison of one- and two-wavelength methods. Graefes Arch Clin Exp Ophthalmol. 2006;244:1565-1574.